Patents by Inventor Shiran GERASSY-VAINBERG

Shiran GERASSY-VAINBERG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING SUITABILITY TO ANTI-TNF ALPHA THERAPY
    Publication number: 20240117438
    Abstract: The present invention is directed to a kit and a method for determining the suitability of a subject to a treatment using a tumor necrosis factor alpha (TNF?). Further provided is a method for treating the subject determined to be suitable for a treatment using a TNF? inhibitor.
    Type: Application
    Filed: December 13, 2023
    Publication date: April 11, 2024
    Inventors: Shai SHEN-ORR, Yehuda CHOWERS, Shiran GERASSY-VAINBERG, Alexandra BLATT, Elina STAROVETSKY, Renaud Gilles GAUJOUX, Naama MAIMON
  • METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS
    Publication number: 20240018592
    Abstract: A method of analyzing the therapeutic efficacy of a therapeutic agent for treating an immune-related disorder is disclosed. The method comprises contacting blood cells of the subject with the agent, measuring the expression of at least 20 genes in the blood cells of the subject; obtaining an immune age value based on the expression of the at least 20 genes, and comparing the immune age value with an immune age value of the subject calculated on the basis of expression of the at least 20 genes in blood cells of the subject, in the absence of the agent.
    Type: Application
    Filed: October 26, 2021
    Publication date: January 18, 2024
    Applicants: Technion Research & Development Foundation Limited, Rambam Med-Tech Ltd.
    Inventors: Shai S. SHEN-ORR, Yehuda CHOWERS, Ayelet ALPERT, Shiran GERASSY-VAINBERG, Erik FELDMAN
  • ASSAYS FOR ASSESSING NEUTRALIZING ANTIBODIES LEVELS IN SUBJECTS TREATED WITH A BIOLOGICAL DRUG AND USES THEREOF IN PERSONALIZED MEDICINE
    Publication number: 20200132686
    Abstract: The invention relates to assays, devices and kits for accurate determination of neutralizing antibodies levels in samples of a subject suffering from an immune-mediated disorder, treated with biological drugs, and for predicting responsiveness to the drug in these patients.
    Type: Application
    Filed: January 9, 2020
    Publication date: April 30, 2020
    Inventors: Yehuda CHOWERS, Sigal PRESSMAN, Alexandra BLATT, Shiran GERASSY-VAINBERG